Your browser doesn't support javascript.
loading
Pharmacokinetic and Bioequivalent Study of Potassium Chloride Sustained-Release Tablet Under Different Dietary Conditions in Healthy Chinese Subjects.
Li, Qin; Yang, Zhuan; Liu, Shi-Jing; Liu, Lin; Chen, Lu; Zhang, Qian; Zhou, Yan; Du, Peng; Zeng, Chen; Li, Na; Zeng, Yan; Xiong, Yun; Liu, Di Jia; Chen, Jiyu; He, Yan.
Afiliación
  • Li Q; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Yang Z; Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, China.
  • Liu SJ; School of Pharmacy, Guizhou Medical University, Guiyang, China.
  • Liu L; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Chen L; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Zhang Q; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Zhou Y; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Du P; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Zeng C; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Li N; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Zeng Y; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Xiong Y; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Liu DJ; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Chen J; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • He Y; Clinical Trials Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Clin Pharmacol Drug Dev ; 12(3): 267-272, 2023 03.
Article en En | MEDLINE | ID: mdl-36321352
ABSTRACT
Potassium (K+ ) is an endogenous substance that is an essential dietary component. However, the interaction between dietary arrangements and specific effects of dietary K+ intake in bioequivalence studies remains unclear. To investigate the influence of dietary arrangement on the bioequivalence of potassium chloride (KCl) sustained-release tablets in healthy Chinese volunteers, the pharmacokinetics of KCl were compared in two open-label, single-center, randomized, two-period crossover studies with different dietary conditions. All volunteers received an oral dose of 6 g of KCl sustained-release tablets under fasting conditions, with different dietary arrangements. Urine samples were collected on baseline days and 48 hours after tablet consumption. Inductively coupled plasma-optical emission spectrometry was used to measure the concentration of K+ in the urine samples. Pharmacokinetic parameters were analyzed using Phoenix WinNonlin software in a noncompartmental model. In either clinical trial, no significant differences were observed in the maximal rate of urinary excretion and cumulative urinary excretion from 0 to 24 hours of K+ between the reference and test drugs. The bioequivalence studies of both KCl sustained-release tablet formulations were successfully conducted under different dietary conditions.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cloruro de Potasio / Equivalencia Terapéutica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cloruro de Potasio / Equivalencia Terapéutica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article